GLP-1 Medication Switching Guides

A complete guide to switching from Ozempic (injectable semaglutide) to Foundayo (oral orforglipron) — including dose mapping, timeline, cost savings, and what to expect.

Complete guide to switching from Wegovy (injectable semaglutide 2.4mg) to Foundayo — with dose mapping, weight maintenance tips, and cost analysis.

Switch from Zepbound (tirzepatide) to Foundayo — different drug classes, what changes, and why Lilly designed this exact transition path.

Switching from Mounjaro (tirzepatide for diabetes) to Foundayo — what changes, dose mapping, and managing both weight and blood sugar.

With the FDA cracking down on compounded GLP-1s, switching to FDA-approved Foundayo is the safest path forward. Here's how.

Compounded tirzepatide faces the same FDA crackdown. Here's your path to an FDA-approved oral alternative.

Switch from Ozempic injections to the new Wegovy pill — same molecule, same company, no more needles. But there's a catch.

Switching from Lilly's tirzepatide to Novo Nordisk's oral semaglutide — a cross-class, cross-company transition.

Everything you need to know about switching from weekly GLP-1 injections to daily oral pills — comparing Foundayo, Rybelsus, and the Wegovy pill.

A comprehensive guide to safely switching between any GLP-1 medications — timing, dose mapping, side effects management, and when to call your doctor.

The FDA is ending the compounded GLP-1 era. Here's your complete guide to transitioning to FDA-approved alternatives — Foundayo, Ozempic, Wegovy, Zepbound, or Mounjaro.

The definitive dose equivalence reference for all GLP-1 medications — semaglutide, tirzepatide, and orforglipron. Based on clinical trial data.